OBJECTIVE: To define further HLA class II gene associations with anticentromere antibody (ACA), a major serum antinuclear antibody in patients with systemic sclerosis (SSc). METHODS: HLA class II genes were determined using polymerase chain reaction/restriction fragment length polymorphisms in 94 Japanese patients with SSc (22 ACA positive and 72 ACA negative) and 50 race matched normal control subjects. RESULTS: Frequency of DQB1*0501 was increased in ACA positive SSc patients compared with ACA negative SSc patients (36% versus 13%; p = 0.02, odds ratio = 4.0, 95% confidence interval 1.1 to 13.9), but the association of ACA with a polar amino acid at position 26 in the DQB1 beta 1 domain, which was demonstrated in white North Americans, was not observed in Japanese. The DRB1*0101, *0405, and *1302 alleles were associated with high ACA titres, whereas DRB1*1502 was associated with low ACA titres and a low frequency of centromere protein C (CENP-C) reactivity. CONCLUSIONS: These results suggest that the ACA response is associated with multiple HLA class II genes and that ACA positive SSc patients are heterogeneous in terms of immunogenetic background.
OBJECTIVE: To define further HLA class II gene associations with anticentromere antibody (ACA), a major serum antinuclear antibody in patients with systemic sclerosis (SSc). METHODS: HLA class II genes were determined using polymerase chain reaction/restriction fragment length polymorphisms in 94 Japanese patients with SSc (22 ACA positive and 72 ACA negative) and 50 race matched normal control subjects. RESULTS: Frequency of DQB1*0501 was increased in ACA positive SSc patients compared with ACA negative SSc patients (36% versus 13%; p = 0.02, odds ratio = 4.0, 95% confidence interval 1.1 to 13.9), but the association of ACA with a polar amino acid at position 26 in the DQB1 beta 1 domain, which was demonstrated in white North Americans, was not observed in Japanese. The DRB1*0101, *0405, and *1302 alleles were associated with high ACA titres, whereas DRB1*1502 was associated with low ACA titres and a low frequency of centromere protein C (CENP-C) reactivity. CONCLUSIONS: These results suggest that the ACA response is associated with multiple HLA class II genes and that ACA positive SSc patients are heterogeneous in terms of immunogenetic background.
Authors: E Genth; R Mierau; P Genetzky; C A von Mühlen; S Kaufmann; H von Wilmowsky; M Meurer; T Krieg; H J Pollmann; P W Hartl Journal: Arthritis Rheum Date: 1990-05
Authors: J D Reveille; E Durban; M J MacLeod-St Clair; R Goldstein; R Moreda; R D Altman; F C Arnett Journal: J Clin Invest Date: 1992-09 Impact factor: 14.808
Authors: W C Earnshaw; K F Sullivan; P S Machlin; C A Cooke; D A Kaiser; T D Pollard; N F Rothfield; D W Cleveland Journal: J Cell Biol Date: 1987-04 Impact factor: 10.539
Authors: P G Vlachoyiannopoulos; U G Dafni; I Pakas; M Spyropoulou-Vlachou; C Stavropoulos-Giokas; H M Moutsopoulos Journal: Ann Rheum Dis Date: 2000-05 Impact factor: 19.103
Authors: Aimee L Hanson; Joanne Sahhar; Gene-Siew Ngian; Janet Roddy; Jennifer Walker; Wendy Stevens; Mandana Nikpour; Shervin Assassi; Susanna Proudman; Maureen D Mayes; Tony J Kenna; Matthew A Brown Journal: Front Genet Date: 2022-06-08 Impact factor: 4.772
Authors: Frank C Arnett; Pravitt Gourh; Sanjay Shete; Chul W Ahn; Robert E Honey; Sandeep K Agarwal; Filemon K Tan; Terry McNearney; Michael Fischbach; Marvin J Fritzler; Maureen D Mayes; John D Reveille Journal: Ann Rheum Dis Date: 2009-07-12 Impact factor: 19.103
Authors: X D Zhou; L Yi; X J Guo; E Chen; H J Zou; L Jin; M D Mayes; S Assassi; J C Wang Journal: Int J Immunopathol Pharmacol Date: 2013 Jul-Sep Impact factor: 3.219